Madan Jagasia
President, CEO & DirectorDr. Madan Jagasia, M.D., M.S., is Member of Medical Advisory Board of Bone Marrow & Cancer Foundation. Dr. Madan Jagasia is Chief Executive Officer and Director of Obsidian Therapeutics, Inc. since January 2023 and its President. He was President and Treasurer of Obsidian Therapeutics, Inc. since March 2023. He had served as Executive Vice President of Medical Affairs at Iovance Biotherapeutics, Inc. since 2022 until January 2023 and served as its Senior Vice President of Medical Affairs until 2022. He was responsible for managing national medical affairs, strategic congress planning, advocacy, strategic alliances and external research collaborations at Iovance Biotherapeutics. Dr. Jagasia is a highly experienced physician executive with an extensive oncology and cell therapy-focused clinical background and deep industry experience developing tumor-infiltrating lymphocyte (TIL) treatments for cancer. Before Iovance, he was Chief Medical Officer and Executive Medical Director of Cancer Patient Care Center, Vanderbilt-Ingram Cancer Center (VICC), where he co-led Translational Research and Interventional Oncology Research Program at VICC. Dr. Jagasia began his career as a faculty member in the Division of Hematology-Oncology at Vanderbilt University Medical Center. Dr. Jagasia has his M.B.B.S from the GS Medical College & KEM Hospital, an M.S. and a Master of Management in Health Care from Vanderbilt University.
Positions
- Company NameObsidian Therapeutics, Inc.Stock CodeOBXPositionPresident, CEO & DirectorColleagues
